Viatris Inc./ US92556V1061 /
10/06/2024 07:57:22 | Var. +0.1640 | Volume | Denaro13:30:05 | Lettera13:30:05 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
9.7420EUR | +1.71% | - Fatturato: - |
9.6400Quantità in denaro: 730 | 9.7740Quantità in lettera: 730 | 11.54 bill.EUR | - | - |
GlobeNewswire
13:30
Lilium launches China Legal Entity as part of collaboration with the Bao’an District of Shenzhen
GlobeNewswire
13:30
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FD...
GlobeNewswire
13:30
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
GlobeNewswire
13:30
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
GlobeNewswire
13:30
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Dee...
GlobeNewswire
13:27
Twelve Seas Investment Company II Announces Third Extension Not to be Implemented and Company to Liq...
GlobeNewswire
13:00
Eyeris Wins “Automotive Tech Company of the Year” and “Automotive Product of the Year” Awards at Aut...
GlobeNewswire
13:00
Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
GlobeNewswire
13:00
Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Cl...
GlobeNewswire
13:00
Green Shift Commodities Closes Private Placement and Enters Definitive Agreement for Sale of Berlin ...
GlobeNewswire
13:00
Critical Metals Corp. to Acquire Tanbreez, One of the World’s Largest Known Rare Earths Assets